Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study.

Neuropharmacology

Department of Molecular Genetics, Instituto de Biología Molecular de Barcelona, CID-CSIC 08034, Barcelona, Spain.

Published: December 2002

Changes in brain cyclic AMP (cAMP) have been suggested to underlie the clinical action of antidepressant treatments. Also, a regionally-selective regulation of cAMP-specific phosphodiesterases (PDEs) has been demonstrated for some antidepressants. To further investigate the effects of antidepressant treatments on PDEs, we examined the expression of different cAMP-specific PDEs in the brain of rats treated (1 and 14 days) with fluoxetine 3 mg/kg day. The mRNAs coding for PDE4A, PDE4B, PDE4D, and the five known PDE4D splice variants were analyzed by in situ hybridization on 45 brain structures of acute and chronic fluoxetine-treated rats. We also examined the binding sites for the putative antidepressant drug [(3)H]rolipram, a PDE4-selective inhibitor. In some brain areas single fluoxetine administration increased the density of the mRNA of all PDE4 isozymes, except PDE4D and PDE4D5. Chronic fluoxetine treatment increased PDE4A mRNA levels and decreased those for PDE4B, PDE4D and PDE4D1 mRNAs in some brain regions. The study was complemented with the analysis of the expression of the transcripts of BDNF. Chronic fluoxetine treatment down-regulated the expression of BDNF. These results show that the expression of PDE4 isozymes is modulated by a clinically relevant fluoxetine dose. The significance of these changes in PDE4 expression to the antidepressant effect of fluoxetine is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0028-3908(02)00220-4DOI Listing

Publication Analysis

Top Keywords

chronic fluoxetine
12
fluoxetine treatment
12
acute chronic
8
situ hybridization
8
antidepressant treatments
8
pde4b pde4d
8
pde4 isozymes
8
fluoxetine
7
expression
6
brain
6

Similar Publications

Amelioration of Gap Junction Dysfunction in a Depression Model by Loganin: Involvement of GSK-3β/β-Catenin Signaling.

J Ethnopharmacol

December 2024

School of Life Sciences & School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100029, People's Republic of China. Electronic address:

Ethnopharmacological Relevance: Comus officinalis Sieb. et Zucc has significant neuroprotective activity and has been widely studied for its potential to improve cognitive function. Our team's previous research has found that loganin isolated from Comus officinalis has an antidepressant effect.

View Article and Find Full Text PDF

Ondansetron blocks fluoxetine effects in immature neurons in the adult rat piriform cortex layer II.

Neurosci Lett

December 2024

Neurobiology Unit, Institute for Biotechnology and Biomedicine (BIOTECMED), University of Valencia, Spain. Electronic address:

Neuronal structural plasticity gives the adult brain the capacity to adapt to internal or external factors by structural and molecular changes. These plastic processes seem to be mediated, among others, by the action of the neurotransmitter serotonin through specific receptors (5-HTRs). Previous studies have shown that the maturation of granule cells in the hippocampus is mediated by 5-HT3.

View Article and Find Full Text PDF

Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy.

Int Immunopharmacol

December 2024

School of Medicine, Guizhou University, Guiyang 550025, China; NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang 550002, China. Electronic address:

Introduction: Depression negatively impacts the prognosis of various cancers, including lung cancer, by influencing antitumor immune responses and impairing immune cell function. Antidepressants may modulate the tumor immune microenvironment, enhancing immunotherapy efficacy. However, the specific mechanisms remain unclear.

View Article and Find Full Text PDF

The molecular mechanism of Xiaoyaosan in treating major depressive disorder: Integrated analysis of DNA methylation and RNA sequencing of the arcuate nucleus in rats.

J Ethnopharmacol

December 2024

School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, PR China; Guangzhou Key Laboratory of Formula-Pattern of Traditional Chinese Medicine, Formula-Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, 510632, PR China. Electronic address:

Ethnopharmacological Relevance: Xiaoyaosan, a classic Chinese herbal formula, exhibits promising antidepressant effects. However, its specific antidepressant mechanisms remain incompletely understood. Previous studies have highlighted the significant role of DNA methylation in the pathogenesis of major depressive disorder (MDD).

View Article and Find Full Text PDF

Evaluation of a user-friendly CSDS cage apparatus for studying depressive-like behaviors in rodents.

Animal Model Exp Med

December 2024

High-Level Key Disciplines of Traditional Chinese Medicine: Basic Theory of Traditional Chinese Medicine, National Administration of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Article Synopsis
  • A new standardized apparatus was developed to improve the chronic social defeat stress (CSDS) model used for studying depression-like behaviors in lab rodents, enhancing both study accuracy and animal welfare.
  • The effectiveness of the new CSDS cage and water bottle was evaluated using various behavioral tests in mice, including tail suspension and forced swimming tests, demonstrating a clear induction of depressive-like behaviors.
  • Results confirmed that the new apparatus successfully increased behaviors indicative of depression, with Fluoxetine treatment reversing these effects, providing a reliable alternative to traditional rodent housing.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!